Sort
82,697 grants matching “vaccine development”
The Neural Basis of the Brain-Body Connection
$1,168,788Peter L Strick · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · AT
Studies of the Function of Naturally Occurring and Adaptive T Regulatory Cells
$1,168,634Ethan Shevach · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Boston Pediatric AIDS Clinical Trials Unit
$1,168,600Children'S Hospital Boston · U01 · FY2003 · AI
Development Of Flow Cytometric Technologies For Immune Assays
$1,168,546Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Development Of Flow Cytometric Technologies For Immune Assays
$1,168,546Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Integrated analysis of HBV-specific CD4 T cell and B cell responses to define their role in chronic hepatitis B and HBV functional cure.
$1,168,511Georg Michael Lauer · Massachusetts General Hospital · R01 · FY2024 · AI
Malaria Transmission Blocking Vaccine Discovery
$1,168,442Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Cancer Immunotherapy Clinical Trials
$1,168,320Julius Strauss · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Antibody Based Therapeuticcs for Chikungunya Virus
$1,167,991Michael S. Diamond · Washington University · R01 · FY2014 · AI
Project 1-Mechanism of Anti-Gp120 Antibody Persistence
$1,167,622Anthony L Devico · University Of Maryland Baltimore · P01 · FY2016 · AI
Miami Pediatric AIDS Clinical Trials Unit
$1,167,578University Of Miami School Of Medicine · U01 · FY2003 · AI
Task D05 Cervid Studies of Transmission and Control of Chronic Wasting Disease
$1,167,485 · N01 · FY2010 · AI
Vermont Immunobiology / Infectious Diseases Center
$1,167,438Ralph C. Budd · University Of Vermont & St Agric College · P30 · FY2017 · GM
Whole Protein Arrays to Detect Antimicrobial Antibodies Associated with Triggering and Progression of Islet Autoimmunity in TEDDY
$1,167,399Joshua Labaer · Arizona State University-Tempe Campus · R01 · FY2025 · DK
Tularemia: Pathogenesis and Host Response
$1,167,308Karl E Klose · University Of Texas San Antonio · P01 · FY2009 · AI
COVID-19 testing and vaccination social network diffusion for diverse criminal legal involved communities
$1,166,973John Schneider · University Of Chicago · U01 · FY2023 · MD
Vermont Immunobiology / Infectious Diseases Center
$1,166,856Ralph C. Budd · University Of Vermont & St Agric College · P30 · FY2018 · GM
Immune Reconstitution
$1,166,782Ronald Gress · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
$1,166,652Mary N. Carrington · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Miami Treatment and Prevention Clinical Trials Unit (CTU)
$1,166,422Dushyantha Jayaweera · University Of Miami School Of Medicine · UM1 · FY2018 · AI
University of Rochester HIV/AIDS Clinical Trials Unit
$1,166,422Michael C Keefer · University Of Rochester · UM1 · FY2017 · AI
Miami Treatment and Prevention Clinical Trials Unit (CTU)
$1,166,422Margaret A Fischl · University Of Miami School Of Medicine · UM1 · FY2017 · AI
University of Rochester HIV/AIDS Clinical Trials Unit
$1,166,421Michael C Keefer · University Of Rochester · UM1 · FY2018 · AI
A Novel Systemic and Mucosal Adjuvant for Biodefense
$1,166,198Robert E. Johnston · Global Vaccines, Inc. · U01 · FY2007 · AI
Task A12: Small Animal Models for Mycobacteria
$1,166,146Linda Monum · Colorado State University · N01 · FY2011 · AI